抗凋亡基因BCL-2启动子区i-motif在急性肾损伤中的机理研究及基于该靶点小分子转录调控策略
批准号:
82100725
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
李小雅
依托单位:
学科分类:
泌尿系统损伤与修复
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
李小雅
中文摘要
急性肾损伤(AKI)是一种发病率死亡率极高的危急重症。BCL-2表达量下降导致AKI早期肾小管细胞过分凋亡。BCL-2基因启动子i-Motif是该基因转录的“分子开关”,稳定i-Motif结构后BCL-2表达量增加。前期研究提示AKI肾小管上皮细胞凋亡模型细胞内i-Motif数量较正常组减少,诱导并稳定该结构后细胞存活率提高,因此我们推论BCL-2启动子i-Motif可能是AKI早期肾小管上皮细胞凋亡的新靶点,稳定i-Motif结构后可上调BCL-2基因表达发挥抗凋亡效应。后期将分别从动物模型、临床实验中研究AKI发病过程中肾小管上皮细胞内BCL-2启动子i-Motif结构及其特异性转录因子hnRNP LL的变化。采用特异性配体小分子对AKI细胞及动物凋亡模型进行干预,阐明i-Motif在AKI发病机制中的作用。为基于抗细胞凋亡的AKI发病机制及其治疗提供新的理论及实验依据。
英文摘要
Acute kidney injury (AKI) is a critical illness with extremely high morbidity and mortality. Decrease of BCL-2 expression is an important factor in the progress of AKI, and it is negatively correlated with the excessive apoptosis of renal tubular cells in the early stage of AKI. i-Motif in the P1 region of BCL-2 gene promoter is the "molecular switch" for the transcription of the gene. The expression of BCL-2 increases after the i-Motif structure is stabilized, and the two are positively correlated. Based on this, we speculate that there is also a negative correlation between i-Motif and the excessive apoptosis of renal tubular cells in the early stage of AKI. i-Motif in the P1 region of the BCL-2 promoter may be a new target for early renal tubular epithelial cell apoptosis in AKI. After stabilizing the structure of i-Motif, it up-regulates the expression of BCL-2 gene. In response to this speculation, we have studied the changes in the structure of i-Motif and its specific transcription factors in the P1 region of the BCL-2 promoter in renal tubular epithelial cells during the pathogenesis of AKI from cells, animals, and clinically. Use specific ligand small molecules to intervene in AKI cells and animal apoptosis models to clarify the role of this structure in the pathogenesis of AKI. Provide a new theory and experimental basis for the research on the pathogenesis and treatment of AKI based on anti-apoptosis.
急性肾损伤(AKI)是一种发病率死亡率极高的危急重症,目前其发病机制未明确,缺乏特异性治疗药物。肾小管上皮细胞过分凋亡是AKI的发病过程中重要特征。BCL-2表达量下降与AKI早期肾小管细胞过分凋亡密切相关。BCL-2基因启动子i-Motif是该基因转录的“分子开关”,稳定i-Motif结构后能够招募相关蛋白形成转录复合体,启动转录,BCL-2基因表达量增加。前期研究提示AKI肾小管上皮细胞凋亡模型细胞内i-Motif数量较正常组减少,诱导并稳定该结构后细胞存活率提高,因此我们推论BCL-2启动子i-Motif可能是AKI早期肾小管上皮细胞凋亡的新靶点,稳定i-Motif结构后可上调BCL-2基因表达发挥抗凋亡效应。后期分别从动物模型、临床实验中研究AKI发病过程中肾小管上皮细胞内BCL-2启动子i-Motif结构及其特异性转录因子hnRNP LL的变化。采用BCL-2启动子i-Motif的特异性配体小分子对AKI细胞及动物凋亡模型进行干预,发现稳定该结构后能上调BCL-2基因的表达,在多种元素诱导的HK-2细胞凋亡模型中能缓解细胞凋亡,同时在AKI的动物模型中能减轻肾脏凋亡,同时改善肾脏组织损伤、炎症反应等病理生理过程。该研究阐明了i-Motif在AKI发病机制中的作用。为基于抗细胞凋亡的AKI发病机制及其治疗提供新的理论及实验依据。
国内基金
海外基金